Geller Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Geller Advisors's LLY Position: Q4 2024 in Review
Geller Advisors reduced its Eli Lilly (LLY) stake by 3.3% in Q4 2024, selling an estimated $108K and leaving 3,895 shares worth $3.01M. The position accounts for 0.2% of the portfolio, ranked #32.
Geller Advisors first reported a position in LLY in Q2 2020 and has held it in 19 quarters since. The position peaked at $3.97M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Geller Advisors held 3,895 shares of Eli Lilly worth $3.01M as of Q4 2024.
- Geller Advisors sold 131 Eli Lilly shares in Q4 2024, an estimated $108K.
- Eli Lilly made up 0.2% of Geller Advisors's portfolio in Q4 2024, its #32 holding.
- Geller Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 19 quarters since.
- Geller Advisors's Eli Lilly position peaked at $3.97M in Q2 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.